About: Effect of the COVID‐19 pandemic on anxiety among children with cystic fibrosis and their mothers

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Effect of the COVID‐19 pandemic on anxiety among children with cystic fibrosis and their mothers Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Effect of the COVID‐19 pandemic on anxiety among children with cystic fibrosis and their mothers
Creator	Aslan, Aslan, Ayse Ayse, Tana Ramaslı Gursoy, Tugba Senkalfa, Burcu Sismanlar Eyuboglu, Tugba Soysal, Azime
Source	Medline; PMC
abstract	BACKGROUND: We aimed to evaluate anxiety among children with cystic fibrosis (CF) and their mothers related to the COVID‐19 pandemic. METHODS: A total of 45 patients with CF and their mothers were enrolled in the study together with 90 age‐matched healthy children and their mothers as a control group. The State and Trait Anxiety Inventory (STAI) was administered by teleconference with children aged 13–18 years old and their mothers. The STAI for children was administered with children aged 9–12 years. Results were compared with age‐matched healthy children and their mothers. The relationship between anxiety scores of children with CF and their mothers was evaluated by comparing with clinical data of children with CF. At the conclusion of the teleconference, mothers were asked whether their anxiety had changed as a result of the interview. RESULTS: It was found that healthy children aged 13–18 years had higher state anxiety scores than age‐matched children with CF. Mothers of children with CF had higher trait anxiety scores, especially those of children aged 0–12 years, than mothers of healthy children (p<0.05). For mothers of children with CF, state anxiety scores were higher among those whose children had chronic Pseudomonas infection (p<0.05). Most mothers of children with CF stated that their anxiety decreased following the interview. CONCLUSION: The COVID‐19 pandemic may increase anxiety among mothers of children with CF as well those with healthy children. However, COVID‐19 had no effect on the anxiety of children with CF. Informing parents of children with CF about COVID‐19 by teleconference may decrease anxiety. This article is protected by copyright. All rights reserved.
has issue date	2020-06-12(xsd:dateTime)
bibo:doi	10.1002/ppul.24900
bibo:pmid	32530552
has license	no-cc
sha1sum (hex)	523d864943e727529dcce5a2ad0fbc373b76f65f
schema:url	https://doi.org/10.1002/ppul.24900
resource representing a document's title	Effect of the COVID‐19 pandemic on anxiety among children with cystic fibrosis and their mothers
has PubMed Central identifier	PMC7307121
has PubMed identifier	32530552
schema:publication	Pediatr Pulmonol
resource representing a document's body	covid:523d864943e727529dcce5a2ad0fbc373b76f65f#body_text
is schema:about of	named entity 'cystic fibrosis' named entity 'cystic fibrosis' named entity 'ANXIETY' named entity 'mothers' named entity 'mothers' named entity 'COVID' named entity 'lung function' named entity 'COVID-19 pandemic' named entity 'health outcomes' named entity 'depression' named entity 'FEV' named entity 'depressive symptoms' named entity 'PFT' named entity 'State-Trait Anxiety Inventory' named entity 'adherence to treatment' named entity 'younger children' named entity 'trait anxiety' named entity 'bronchiectasis' named entity 'depression' named entity 'China' named entity 'STAI' named entity 'pediatric pulmonology' named entity 'STAI' named entity 'anxiety' named entity 'treatment compliance' named entity 'Cystic fibrosis' named entity 'Pseudomonas aeruginosa' named entity 'Hubei' named entity 'affect the health' named entity 'H1N1' named entity 'Pseudomonas aeruginosa' named entity 'anxiety' named entity 'anxiety' named entity 'nutritional status' named entity 'State-Trait Anxiety Inventory' named entity 'cross-sectional study' named entity 'severe pneumonia' named entity 'anxiety' named entity 'anxiety' named entity 'anxiety' named entity 'STAI' named entity 'control group' named entity 'anxiety' named entity 'COVID-19' named entity 'severe anxiety' named entity 'chronic illnesses' named entity 'control groups' named entity 'pulmonologist' named entity 'trait anxiety' named entity 'lung disease' named entity 'snowball sampling' named entity 'anxiety' named entity 'physical examination' named entity 'headache' named entity 'COVID' named entity 'lung function' named entity 'anxiety' named entity 'spirometry' named entity 'muscle pain' named entity 'control group' named entity 'mechanical ventilation' named entity 'depression' named entity 'general population' named entity 'human infection' named entity 'respiratory infections' named entity 'quality of life' named entity 'anxiety' named entity 'inflammatory' named entity 'anxiety' named entity 'FEV1' named entity 'forced expiratory volume' named entity 'anxiety' named entity 'control group' named entity 'COVID' named entity 'lung function'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software